Crescent Capital has priced its latest collateralised loan obligation (CLO), Atlas Senior Loan Fund XXVIII (Atlas 28), at $406.9m (£303m).

The transaction is the alternative credit manager’s second new-issue CLO of 2026 and the fourth issued through its CLO Equity Fund II, which held its final close in August.

The deal attracted 20 investors and will invest primarily in US senior secured term loans, alongside selected senior secured corporate bonds.

Read more: BSP closes $1.1bn commercial real estate CLO

“We are grateful for the continued support of our longstanding investors and pleased to welcome several new investors to the platform through this transaction,” said Nilesh Mandhare, managing director, portfolio manager and head of the CLO issuance business at Crescent Capital.

“Volatility in the leveraged loan market provided opportunities for our experienced team to selectively acquire assets at attractive prices, reflecting Crescent’s disciplined and patient approach to portfolio construction.”

Read more: Obra Capital closes fifth CLO at $404m

Crescent has $53bn of assets under management and has issued and managed just under $20bn of CLOs since 1992.

Read more: Polus resets US CLO at $400m